Cardiovascular diseases (CVD) are one of the main causes of death in the world, accounting for 31% of global deaths, 1 and 85% of these deaths are caused by coronary events and cerebral vascular accidents. [1][2][3] in Brazil, at least 20% of individuals older than 30 years of age die from CVD, with discrepancies in mortality rates between the five main geographic regions of the country. In the state of Bahia, 24.1% of deaths (27.3% of them in the city of Salvador) 4 were from acute myocardial infarction (AMI) between 2008 and 2018, and therefore, this condition is one of the most important causes of cardiovascular deaths in the state.
AMI may have different clinical presentations,including the ST-segment elevation myocardial infarction (STEMI), in which a complete occlusion of the coronary artery occurs. 5 A delay in the diagnosis of STEMI, and consequently in myocardial reperfusion increases morbidity and mortality. 5,6 Therefore, treatment success is associated with an immediate access to reperfusion therapy to restore blood flow, 6,7 which increases survival and reduces the risk of complications. 8 Potential complications of AMI include reinfarction, heart failure, angina, and death. 5 In addition, mental health status may be affected in some patients, who have